-transparent.png){kind=logo}
The use of an artificial pancreas for blood glucose monitoring and feedback correction for evaluation and improvement of subcutaneous insulin therapy facilitates the process of finding an optimal therapy regime for the individual patient. The frequency of hypoglycemic episodes can be reduced while maintaining good control, and hospital stays can be considerably shortened. This procedure is particularly useful in achieving tight control in pregnant diabetics.
Related Publications
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
June 1979,
Medical progress through technology,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
July 1982,
Pediatrics,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
August 1978,
British medical journal,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
July 1984,
Acta endocrinologica,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
August 1978,
Clinical chemistry,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
August 1981,
Diabetologia,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
January 1977,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
March 1979,
Diabetologia,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
January 1988,
The Tohoku journal of experimental medicine,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
M Franetzki
March 1981,
Diabete & metabolisme,
